Pheton Holdings Current Ratio 1970-1969 | PTHL
Pheton Holdings current ratio from 1970 to 1969. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Pheton Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.032B | 15.37 |
| Cencora (COR) | United States | $46.213B | 17.66 |
| ICON (ICLR) | Ireland | $24.133B | 21.69 |
| DiDi Global (DIDIY) | China | $18.810B | 0.00 |
| Avantor (AVTR) | United States | $18.267B | 27.70 |
| Natera (NTRA) | United States | $15.734B | 0.00 |
| Revvity (RVTY) | United States | $15.135B | 26.50 |
| Viatris (VTRS) | United States | $14.107B | 4.30 |
| CochLear (CHEOY) | Australia | $12.791B | 0.00 |
| Solventum (SOLV) | United States | $12.492B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.995B | 33.36 |
| Charles River Laboratories (CRL) | United States | $10.647B | 20.12 |
| Sonic Healthcare (SKHHY) | Australia | $8.854B | 0.00 |
| Doximity (DOCS) | United States | $7.456B | 47.25 |
| HealthEquity (HQY) | United States | $6.881B | 37.35 |
| Bausch + Lomb (BLCO) | Canada | $6.534B | 28.12 |
| PACS (PACS) | United States | $6.213B | 0.00 |
| Organon (OGN) | United States | $5.291B | 5.38 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.718B | 23.80 |
| Surgery Partners (SGRY) | United States | $3.989B | 44.20 |
| Concentras Parent (CON) | United States | $2.938B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.880B | 108.43 |
| BrightSpring Health Services (BTSG) | United States | $2.510B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.458B | 0.00 |
| Progyny (PGNY) | United States | $2.241B | 39.40 |
| Alignment Healthcare (ALHC) | United States | $2.234B | 0.00 |
| Premier (PINC) | United States | $2.057B | 9.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.980B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.751B | 8.79 |
| CareDx (CDNA) | United States | $1.589B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.560B | 0.00 |
| Agilon Health (AGL) | United States | $1.498B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.217B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.000B | 0.00 |
| Embecta (EMBC) | United States | $0.952B | 6.35 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.906B | 9.86 |
| InnovAge Holding (INNV) | United States | $0.807B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.532B | 0.00 |
| Sharecare (SHCR) | United States | $0.519B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.494B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 34.78 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 13.73 |
| Sera Prognostics (SERA) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.261B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.191B | 0.00 |
| MultiPlan (MPLN) | United States | $0.168B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.086B | 20.73 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.082B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.65 |
| Singular Genomics Systems (OMIC) | United States | $0.040B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |